Zhuhai Rundu Pharmaceutical (002923.SZ): The hydrochloride of meperidine injection obtained the drug registration certificate.

17:15 03/04/2026

Runthu Group (002923.SZ) announcement: The company has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the injection of methylergometrine maleate. This product is used for cardiac stress testing, suitable for myocardial perfusion imaging (MPI) to evaluate myocardial ischemia.

Zhuhai Rundu Pharmaceutical (002923.SZ) annonuced that the company has received the Drug Registration Certificate for the injection of Desmethyllevomilnacipran Hydrochloride issued by the National Medical Products Administration. This product is a drug used for cardiac load testing and is suitable for Myocardial Perfusion Imaging (MPI) to evaluate myocardial ischemia.

New stock news | Shenzhen Salubris Pharmaceuticals (002294.SZ) plans to list on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires clarification on the proportion of fundraising for domestic and overseas purposes.

The Shanghai Stock Exchange releases the annual report of publicly offered Real Estate Investment Trusts (REITs) in the Shanghai market for 2025: A total of 52 products generated a combined revenue of 14.5 billion yuan for the year, representing a 71% year-on-year increase.

Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.